Journal
Six guides built around provenance, denominators, regulatory context, and the line between anecdotal and clinical evidence.
A provenance-first guide to interpreting public BPC-157 experience reports without confusing anecdote with clinical data.
Read guide →How Anecdotal separates reported outcomes, effects, side effects, and product context in public ashwagandha accounts.
Read guide →A plain-language introduction to Anecdotal’s structured experience-report platform and its limits.
Read guide →A structured way to read longevity-community rapamycin reports while keeping prescription status and evidence limits visible.
Read guide →How reported ashwagandha amounts are grouped, normalised, and displayed without turning anecdotal ranges into instructions.
Read guide →How to distinguish frequently repeated creatine claims from side effects actually recorded in a structured report set.
Read guide →